Thus, the tubuloglomerular feedback theory has been widely believed to attenuate the diabetic kidney and heart by SGLT2 inhibitors; however, SGLT2 inhibitors may not induce Na+ uresis and may not increase the Na+ concentration in tubules in the kidney than previously expected. Here, SLC5A2 is linked to urogenital neoplasm.